Skip to content

The Personalized Chinese Herb Formulas Over Hypertensive Bradyarrhythmia

The Personalized Chinese Herb Formulas Are Evaluated for Their Effectiveness to Relieve Symptoms in Hypertensive Bradyarrhythmia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04505228
Enrollment
72
Registered
2020-08-10
Start date
2020-01-20
Completion date
2020-06-20
Last updated
2020-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertensive Heart Disease

Brief summary

72 patients who have been diagnosed with hypertensive bradyarrhythmia were selected and randomly divided into research group and control group. The research group received regular medication against hypertension and the personalized formulas based on syndrome differentiation, meanwhile the control group only received the regular medication. The five symptoms (palpitation, short of breath, angina, dizzy and lumbar debility) were graded and used for evaluation of treatment.

Detailed description

To test the effect of Chinese herb against the hypertensive heart disease, we designed this randomized controlled clinical trial. 72 patients who have been diagnosed with hypertensive bradyarrhythmia were selected and randomly divided into research group and control group. The five symptoms (palpitation, short of breath, angina, dizzy and lumbar debility) were graded. The research group received regular medication against hypertension and the personalized formulas based on syndrome differentiation, meanwhile the control group only received the regular medication. 2 weeks after treatment, all the symptoms were graded again.

Interventions

DRUGSafflower (Carthamus Tinctorius) IgG4 | Serum | Allergy

The designed Chinese herb formulas

The basic treatment for heart disease

Sponsors

Qingdao Fifth People's Hospital
CollaboratorUNKNOWN
Jun Xiao
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

\* Clinical diagnosis of hypertensive bradyarhhythmia

Exclusion criteria

* With other elementary diseases * With pregnant * With receiving other treatment within past half year from the beginning of trial.

Design outcomes

Primary

MeasureTime frameDescription
typical symptoms in patients with hypertensive bradyarrhythmia2 weeksThe five indexes of typical symptoms in patients with hypertensive bradyarrhythmia (palpitation, angina, shortness of breath, dizzy, lumbar debility) were evaluated and scored both before treatment and after treatment according to Guiding principles for clinical research of new Chinese Medicine.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026